EZH2 and neoplasm: Moreover, EZH2-mediated H3K27me3 induces the silencing of the IL-15R, CD122, and NKG2D receptor proteins, hence suppressing NK-cell expansion and decreasing the cytotoxic targeting of tumor cells.